Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

New Microplate Designed for High-Resolution Microscopy

By BiotechDaily International staff writers
Posted on 12 Mar 2013
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
A new, black 96-well microplate includes an ultra-low well base that enables high-magnification microscopy, inclusive of perimeter wells, even with a minimum working distance.

Greiner Bio-One (Frickenhausen, Germany) now expands its microplate portfolio with the introduction of “ScreenStar” at the 2013 Society for Laboratory Automation and Screening (SLAS) conference exhibition in Orlando (FL, USA). The ScreenStar design includes several new features. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, it facilitates outstanding image quality of well contents. The microplate has a 190 μm ultraclear film bottom. The key advantage of ScreenStar over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven cell culture-treatment quality ensures reliable, uniform growth.

The black, 96-well, 190 μm clear film bottom, cell culture treated, cycloolefin ScreenStar microplate comes sterile with lid, individually packed. Well bottoms are protected by a film that must be removed prior to use. The identical microscopy plate with a glass bottom will be introduced shortly.

Related Links:
Greiner Bio-One



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.